1 completed, 1 suspended. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Suspended 1 |
| Phase 2 | 1 | Suspended 1 |
Follow Zinlirvimab: new trials by email Literature Review of Zinlirvimab trials Research Report on Zinlirvimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1 ChAdOx1.tHIVconsv1, ChAdOx1.HIVconsv62, MVA.tHIVconsv3 - HIV-1-infection | Phase 1 / Phase 2 | Suspended | National Institute of Allergy and Infectious Diseases (NIAID) | 36 | 2024-04-01 | 2026-09-02 |
| Study to Evaluate the Safety and Efficacy of Teropavimab and Zinlirvimab in Combination With Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection Oral Lenacapavir, Subcutaneous Lenacapavir, Teropavimab - HIV-1 Infection | Phase 1 | Completed | Gilead Sciences | 32 | 2021-04-08 | 2025-01-27 |
Gilead Sciences (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (2) · Brazil (1)